Advertisement
Indian
India, ADB sign $300 million loan to improve primary health care in India
After signing the loan agreement, Mishra said that the programme...
NITI floats idea of full-stack digital banks, seeks comments by Dec 31
Digital banks or DBs are banks as defined in the Banking Regulation...
Star Health IPO to open on Nov 30; sets price band at Rs 870-900/share
Those offering shares through the offer-for-sale are promoter and...
Delhi HC admits Singh’s appeal challenging Tripathy’s appointment as CMD of UII
``The petitioner (Singh) is seeking necessary orders from the Court...
International
Covid-19 Pandemic:Insurers to see erase profits until 2021 second half, says Fitch
Gilead ties up with Indian phrma cos for COVID-19 drug supply
The countries consist of nearly all low-income and lower-middle income ones, as well as several that are upper-middle- and high-income, the drugmaker said. Afghanistan, India, North Korea, Pakistan and South Africa are among the countries.
The licensees will also set their own prices for the generic product they produce, Gilead said.
The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding COVID-19, or until a product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, the company said.
Aon sets up MGA with world’s largest capacity for Intellectual Property Liability Risks
It is the latest offering from Aon to meet the changing needs of clients’ intellectual property (IP) exposures, especially in this distressed economic environment.Target markets include businesses of all sizes from SMEs to multi-national corporations in North America, Europe, Australia, New Zealand and parts of Asia
-Primary limit of indemnity of up to $100 million (€100 million)
South Korea reports 34 new coronavirus cases,highest in a month
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.